Therefore, by combining TMT labeling-based proteomic analysis with previous findings, we explored the roles of CDK6 and MAP3K6 in lung cancer development and the relationship between YTHDF1, CDK6, and MAP3K6. This evidence concerns the gene CDK6 and lung carcinoma.